Your profile :General public|Researcher|Student|Companies / Communities
 
Labex Toucan
Investissements d'avenir
Home   ›   Your profile   ›   Company / Community Print this page
 

Company / Community

The Labex, what is it ?

The 5 year long Labex Toucan project is endowed with 5 million euros. It will favor the convergence of research on hematopoietic cancers.

News

Calendar

Objectives & approaches

Cancers in relation with blood production organs (leukemia, lymphomas…) still resist to current treatments in an unexplained way. Therefore, the Labex Toucan aims at finding innovating ways in the treatment of these diseases so relapses can be avoided.

Testimonials

Interviews of Fanny Lafouresse, Srdana Grgurevic and Stéphane Pyronnet...

Latest developments and evolutions

Fighting cancer: health issues and economic driving force.

The Oncopole

The Oncopole, the convergence of research on cancer.

First Achievements

The 5 year long project Toucan aims at registering at least two patents of medicines in hematology and oncology.

Glossary

Partners & support

Contact us

Mobile site Laboratoire d’Excellence Toulouse CancerLaboratoire d’Excellence Toulouse Cancer
Calendar

ILSG - 23rd annual meeting
2014, 2nd-4th of June
Tools
ContactContact
MapMap
DirectoryDirectory
GlossaryGlossary
PartnersPartners
               
Inserm CNRS Université Toulouse 3 - Paul Sabatier Université Joseph Fourier - Grenoble Agence Nationale de la Recherche Fondation RITC